Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I B Vergote

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Der Gynakologe|April 1, 1994
[Adjuvant postoperative treatment of endometrial cancer]I B Vergote
Current Opinion in Oncology|September 1, 1993
Surgery for gynecologic malignanciesI B Vergote
Current Opinion in Obstetrics & Gynecology|February 1, 1997
Exenterative surgeryI B Vergote
Gynecologic Oncology|March 1, 1992
Laser excision of the transformation zone as treatment of cervical intraepithelial neoplasia with satisfactory colposcopyI B Vergote, A P Makar, K E Kjørstad
Contraception, Fertilite, Sexualite (1992)|March 1, 1997
[Future organization of oncologic gynecology: results of an international survey]I B Vergote, C F de Oliveira, D Dargent
American Journal of Obstetrics and Gynecology|July 1, 1987
Evaluation of serum CA 125 levels in the monitoring of ovarian cancerI B Vergote, O P Børmer, V M Abeler
Gynecologic Oncology|August 1, 1992
Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second lookK Ramm, I B Vergote, J Kaern, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinomaG B Kristensen, M Baekelandt, I B Vergote, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancerC Marth, C Tropé, I B Vergote, et al.
Cancer|September 1, 1990
Management of malignant ovarian immature teratoma. Role of adriamycinI B Vergote, V M Abeler, K E Kjørstad, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Der Gynakologe|April 1, 1994
[Adjuvant postoperative treatment of endometrial cancer]I B Vergote
Current Opinion in Oncology|September 1, 1993
Surgery for gynecologic malignanciesI B Vergote
Current Opinion in Obstetrics & Gynecology|February 1, 1997
Exenterative surgeryI B Vergote
Gynecologic Oncology|March 1, 1992
Laser excision of the transformation zone as treatment of cervical intraepithelial neoplasia with satisfactory colposcopyI B Vergote, A P Makar, K E Kjørstad
Contraception, Fertilite, Sexualite (1992)|March 1, 1997
[Future organization of oncologic gynecology: results of an international survey]I B Vergote, C F de Oliveira, D Dargent
American Journal of Obstetrics and Gynecology|July 1, 1987
Evaluation of serum CA 125 levels in the monitoring of ovarian cancerI B Vergote, O P Børmer, V M Abeler
Gynecologic Oncology|August 1, 1992
Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second lookK Ramm, I B Vergote, J Kaern, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinomaG B Kristensen, M Baekelandt, I B Vergote, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancerC Marth, C Tropé, I B Vergote, et al.
Cancer|September 1, 1990
Management of malignant ovarian immature teratoma. Role of adriamycinI B Vergote, V M Abeler, K E Kjørstad, et al.
Pageof 4